Schroder Investment Management Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.1M | Sell |
|
|||||
|
2025
Q1 | $73.6M | Sell |
|
|||||
|
2024
Q4 | $65.3M | Sell |
|
|||||
|
2024
Q3 | $95.3M | Sell |
|
|||||
|
2024
Q2 | $107M | Buy |
|
|||||
|
2024
Q1 | $87.1M | Sell |
|
|||||
|
2023
Q4 | $94.8M | Buy |
|
|||||
|
2023
Q3 | $67.2M | Sell |
|
|||||
|
2023
Q2 | $68.6M | Buy |
|
|||||
|
2023
Q1 | $56.2M | Sell |
|
|||||
|
2022
Q4 | $57.7M | Buy |
|
|||||
|
2022
Q3 | $31.5M | Buy |
|
|||||
|
2022
Q2 | $15.2M | Sell |
|
|||||
|
2022
Q1 | $15.7M | Buy |
|
|||||
|
2021
Q4 | $10.1M | Sell |
|
|||||
|
2021
Q3 | $8.56M | Buy |
|
|||||
|
2021
Q2 | $8.93M | Buy |
|
|||||
|
2021
Q1 | $5.58M | Buy |
|
|||||
|
2020
Q4 | $6.04M | Sell |
|
|||||
|
2020
Q3 | $7.05M | Sell |
|
|||||
|
2020
Q2 | $23.8M | Buy |
|
|||||
|
2020
Q1 | $2.7M | Sell |
|
|||||
|
2019
Q4 | $2.64M | Sell |
|
|||||
|
2019
Q3 | $8.49M | Buy |
|
|||||
|
2019
Q2 | $834K | Sell |
|
|||||
|
2019
Q1 | $6.31M | Sell |
|
|||||
|
2018
Q4 | $5.7K | Buy |
|
|||||
|
2018
Q3 | $6.48M | Buy |
|
|||||
|
2018
Q2 | $4.03M | Buy |
|
|||||
|
2018
Q1 | $4.15M | Buy |
|
|||||
|
2017
Q4 | $3.62M | Hold |
|
|||||
|
2017
Q3 | $3.62M | Sell |
|
|||||
|
2017
Q2 | $4.25M | Buy |
|
|||||
|
2017
Q1 | $3.32M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $488K | Sell |
|
|||||
|
2016
Q1 | $908K | Sell |
|
|||||
|
2015
Q4 | $2.44M | Sell |
|
|||||
|
2015
Q3 | $3.85M | Buy |
|
|||||
|
2015
Q2 | $1.41M | Hold |
|
|||||
|
2015
Q1 | $1.39M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $691K | Hold |
|
|||||
|
2013
Q2 | $729K | Buy |
|